← Back to Search

Intervention group for Symptom Management (Persist Trial)

N/A
Waitlist Available
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Persist Trial Summary

This trial will assess the feasibility of using a smartphone app to help manage anxiety and depression for cancer patients receiving radiation treatments.

Eligible Conditions
  • Symptom Management
  • Treatment Non-Adherence

Persist Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety

Persist Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
Intervention group will receive same measures and interventions as the assessment only group AND will receive messaging that is tailored to patient responses on EMAs. When participants provide a pattern of responses that are suggestive of heightened emotional distress, they will receive feedback and/or a prompt to complete one of the self-management exercise. The app will prompt participants to complete a brief educational video on relaxation strategies and guided relaxation exercises. Participants will have access to: 1) a "Help me Cope" button in the app that contains links to evidenced-based self-management techniques, and 2) a "Contact Counselor" button that will send a secure email to a study psychologist requesting a call. Participants will receive a coping focused message at the completion of the "Report Distress" EMAs. Participants can access these on demand intervention components and review them at any time in addition to receiving the tailored intervention messages.
Group II: Assessment only groupExperimental Treatment1 Intervention
Standard care + Daily ecological momentary assessments (EMAs)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Assessment only group
2020
N/A
~60
Intervention group
2016
N/A
~4530

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,553 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Project Persist: mHealth for Cancer Survivorship
2020. "Project Persist: mHealth for Cancer Survivorship". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04126642.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top